Skip to main content

Cue Biopharma, Inc.

CUE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001645460

In the last 90 days, Cue Biopharma, Inc. insiders filed 0 open-market purchases and 3 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $52.2M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Cue Biopharma, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of CUE: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders7775−2
Shares16.4M13.8M−2.58M (−15.7%)
Value$31.0M$17.1M−$13.9M (−44.7%)

New holders (20)

Institutions that held Cue Biopharma, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to CUE in Q2 2024
InstitutionSharesValue% of portfolio
Y-Intercept (Hong Kong) Ltd153,632$190.5K0.01%
Jane Street Group, LLC98,608$122.3K0.00%
Qube Research & Technologies Ltd80,234$99.5K0.00%
Centiva Capital, LP66,894$82.9K0.00%
Point72 Asia (Singapore) Pte. Ltd.53,027$65.8K0.01%
HRT Financial LP52,828$65.0K0.00%
Paloma Partners Management Co32,595$40.4K0.00%
Schonfeld Strategic Advisors LLC24,000$29.8K0.00%
Ground Swell Capital, LLC18,428$22.9K0.02%
Mirae Asset Global ETFs Holdings Ltd.17,897$22.2K0.00%
Point72 (DIFC) Ltd11,527$14.3K0.00%
Balyasny Asset Management LLC10,744$13.3K0.00%
Catalyst Funds Management Pty Ltd9,000$11.2K0.00%
Cubist Systematic Strategies, LLC4,148$5.14K0.00%
GWM Advisors LLC2,550$3.16K0.00%
Macquarie Group Ltd1,805$2.24K0.00%
Cypress Capital, LLC720$8930.00%
SRS Capital Advisors, Inc.215$2670.00%
Innealta Capital, LLC49$610.00%
Farther Finance Advisors, LLC43$440.00%

Sold out (22)

Institutions that held Cue Biopharma, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.